{"transactions":[{"id":2000206,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-22T19:38:27.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on February 21, 2024 and the remaining RSUs vest in eight (8) equal quarterly installments thereafter."}],"balance_after":407080,"source":{"system":"sec-edgar","filing":"0001209191-23-011945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919123011945/doc4.xml","form_type":"4"}},{"id":2344934,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-08T16:43:02.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":310160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on March 8, 2023. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. The option is early exercisable."}],"balance_after":310160,"derivative":{"exercise_price":8.1,"exercise_date":"2022-03-08","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":310160},"source":{"system":"sec-edgar","filing":"0001209191-22-017119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919122017119/doc4.xml","form_type":"4"}},{"id":2344933,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-08T16:43:02.000Z","date":"2022-03-08","kind":"grant","acquired":true,"shares":155080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 8, 2023 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":182080,"source":{"system":"sec-edgar","filing":"0001209191-22-017119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919122017119/doc4.xml","form_type":"4"}},{"id":2652072,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-29T18:12:57.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter.  The option is early exercisable."}],"balance_after":54000,"derivative":{"exercise_price":21.67,"exercise_date":"2021-06-04","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001209191-21-043744","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121043744/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-08"}},{"id":2652071,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-29T18:12:57.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\").  Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001209191-21-043744","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121043744/doc4a.xml","form_type":"4/A","original_submission_date":"2021-06-08"}},{"id":2677884,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T18:04:15.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":53180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on April 22, 2022. The remaining shares subject to the option vest in twelve (12) equal quarterly installments thereafter.  The option is early exercisable."}],"balance_after":53180,"derivative":{"exercise_price":21.67,"exercise_date":"2021-06-04","expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":53180},"source":{"system":"sec-edgar","filing":"0001209191-21-038994","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121038994/doc4.xml","form_type":"4"}},{"id":2677883,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-08T18:04:15.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":26590,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\").  Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on April 22, 2022 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter."}],"balance_after":26590,"source":{"system":"sec-edgar","filing":"0001209191-21-038994","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121038994/doc4.xml","form_type":"4"}},{"id":2739741,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series B' Preferred Stock","published_at":"2021-04-26T17:16:21.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":7219,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":7219},"source":{"system":"sec-edgar","filing":"0001209191-21-028324","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121028324/doc4.xml","form_type":"4"}},{"id":2739740,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series A' Preferred Stock","published_at":"2021-04-26T17:16:21.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":343,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock at any time upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":343},"source":{"system":"sec-edgar","filing":"0001209191-21-028324","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121028324/doc4.xml","form_type":"4"}},{"id":2739739,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-26T17:16:21.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":15385,"price":0.03,"value":461.55,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees."}],"balance_after":22947,"source":{"system":"sec-edgar","filing":"0001209191-21-028324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121028324/doc4.xml","form_type":"4"}},{"id":2739738,"issuer":{"id":5459,"kind":"organization","name":"NeuroPace Inc","symbol":"NPCE"},"owners":[{"id":116624,"kind":"person","name":"Favet Michael","position":1,"cik":"0001855656","reported_name":"Favet Michael","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-04-26T17:16:21.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":7562,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are held by the Favet Living Trust, of which the Reporting Person and the Reporting Person's spouse serve as co-trustees."}],"balance_after":7562,"source":{"system":"sec-edgar","filing":"0001209191-21-028324","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1855656/000120919121028324/doc4.xml","form_type":"4"}}]}